Inhibitor Therapeutics, Inc. (INTI): Net Income
-$3.30M
Year ended 2025-12-31
-$3.31M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$3.30M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$3.34M | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$3.03M | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $12.11M | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | -$298.6K | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$1.06M | n/m | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | -$2.73M | n/m | 2021-03-26, From 2019-01-01 |
| 2018-12-31 | -$4.55M | n/m | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$5.10M | n/m | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | -$7.00M | n/m | 2018-02-16, From 2016-01-01 |
| 2015-12-31 | -$3.95M | n/m | 2017-02-17, From 2015-01-01 |
| 2014-12-31 | -$3.98M | n/m | 2016-02-01, From 2014-01-01 |
| 2013-12-31 | -$1.84M | n/m | 2015-02-13, From 2013-01-01 |
| 2012-12-31 | $186.4K | n/a | 2014-04-15, From 2012-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Inhibitor Therapeutics, Inc. (INTI) | 2025-12-31 | -$3.30M | n/m |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$18.63M | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | -$5.02M | n/m |
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | -$12.88M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$6.50M | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$62.15M | n/m |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | -$2.91M | n/m |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | -$4.18M | n/m |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | -$12.56M | n/m |
Compare INTI, VCNX, LIPO, ARTL side by side · Screen every company in Pharmaceutical Preparations ↗